Strides acquires FDA-approved facility in US
Update: 2019-08-28 00:57 IST
Bengaluru: Bengaluru-headquartered Strides Pharma Science Limited on Tuesday announced that its step down subsidiary Strides Pharma Inc (SPI) has acquired a USFDA-approved manufacturing facility in Florida, USA, from Micelle BioPharma Inc.
Micelle's facility is based in Riviera Beach, Florida, and is one of the very few manufacturing facilities in the US with a softgel capsule (SGC) manufacturing suite for formulations with containment needs, Strides said.